A massive, yet often unnoticed, business practice contributing to exorbitant drug prices in the U.S. may slowly be moving toward reform, according to a recent announcement by the largest practitioner.
Is Reform Coming to Pharmacy Benefit Managers?
Comment
Show comments
Hide Comments
